Athera was a clinical stage biopharmaceutical company focused on developing targeted anti-inflammatory biological candidate drugs for the prevention and treatment of immunovascular disease. The Company initiated its lead program in 2005, based on innovations made at Karolinska Institutet, Sweden. The development of the antibody therapy was in part co-financed by the EU FP7 program, in the project CARDIMMUN. Athera closed down operations in 2021, after reporting of a clinical Phase 2 study.
View Top Employees from Athera Biotechnologies AB| Website | http://www.athera.se |
| Revenue | $1 million |
| Employees | 8 (1 on RocketReach) |
| Founded | 2005 |
| Address | 117 Sankt Eriksgatan, Stockholm, Stockholm County, SE |
| Phone | +46 76 193 81 90 |
| Technologies |
JavaScript,
HTML,
PHP
+14 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Business Services General, Business Services, Science and Engineering, Drug Discovery, Pharmaceutical, Health Care |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Athera Biotechnologies AB employee's phone or email?
Athera Biotechnologies AB Questions
The Athera Biotechnologies AB annual revenue was $1 million in 2024.
1 people are employed at Athera Biotechnologies AB.
Athera Biotechnologies AB is based in Stockholm, Stockholm County.
The NAICS codes for Athera Biotechnologies AB are [541713, 54, 54171, 541, 5417].
The SIC codes for Athera Biotechnologies AB are [87, 873].
Top Athera Biotechnologies AB Employees
Related Companies
